Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

HBV HBeAg and HBsAg secretion inhibitors identified at Roche

April 27, 2021

Janssen R&D Ireland divulges new antituberculous compounds

April 27, 2021

Immunome reports preclinical data on SARS-CoV-2 antibody cocktail IMM-BCP-01

April 26, 2021

Zyesami and Veklury studied within new ACTIV-3 Critical Care study for severe COVID-19

April 26, 2021

Collaboration promotes new antimalarial drug development

April 26, 2021

Phase IIb data for R-21 malaria vaccine adjuvanted with Matrix-M

April 26, 2021

Roche presents HBsAg secretion inhibitors

April 23, 2021

SAB-185 studied as part of ACTIV-2 trial for treatment of COVID-19

April 22, 2021

Sangamo Therapeutics presents new compounds for prion diseases

April 22, 2021

Novartis and Gilead Sciences patent compounds for herpes virus infections

April 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...